In a strongly worded post on LinkedIn, FITTR co-founder Jitendra Chouksey said the company will not incorporate GLP-1 drugs into its fitness programs, calling the approach “unethical.”

Chowksey took a jibe at his competitors who have incorporated GLP-1 in their fitness programs. While he did not took name, the jibe was aimed at companies like Healthifyme, TheGoodBug, and SugarFit, which have started to integrate GLP-1 programs.

“Our competitors have leaped into the opportunity, so it would be very easy for us to do the same. But insiders and people who’ve known me know that I’d much rather die than do something unethical.”
— Jitendra Chouksey, Co-founder, FITTR (LinkedIn post)

The co-founder also revealed the company’s financial health and opined that they are very profitable and growing.

The statement comes at a time when many Indian celebrities like Karan Johar, Ram Kapoor, Tamannaah Bhatia, Kusha Kapila, etc. are believed to have taken GLP-1 drugs for their noticeable weight loss.

The Founder opined that he often gets messages stating the business will be down due to his hard stance on medicines.

Often Posts Against the Healthcare Ecosystem

Chowkesy’s posts on LinkedIn often reflect his criticism of the healthcare ecosystem. He recently shared an ordeal of his co-founder, whose mother has been undergoing chemotherapy for the last 5 years and has gone from Stage 2 to Terminal. Now, the doctors are suggesting that she try “new experimental treatment” which has a 5% chance but will cost 3 cr inr.